Skip to main content
Clinical Trials/DRKS00022239
DRKS00022239
Completed
Phase 2

Evaluation of a new rehabilitation concept for children and adolescents with child and adolescent psychiatric disorders with a focus on participation impairment

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
F20
Sponsor
Institut für rehabilitationsmedizinische Forschung an der Universität Ulm
Enrollment
480
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 18, 2020
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Children and adolescents with the following ICD\-10 F diagnoses (also possible as secondary diagnosis):
  • \- F20 Schizophrenia
  • \- F90 ADHD / hyperkinetic disorder
  • \- F91 Conduct disorders
  • \- F92 Mixed disorders of conduct and emotions
  • \- F94\.1 ff (Reactive) attachment disorder of childhood
  • \- F32\.1 ff moderate depressive episodes
  • \- F33 recurrent depressive disorder
  • \- F40/41 anxiety and phobic disorders
  • \- F42 Obsessive\-compulsive disorder

Exclusion Criteria

  • Insufficient knowledge of the German language;
  • Children and adolescents with certain other diagnoses that occur in addition to one or more of the above\-mentioned ICD\-10 F diagnoses:
  • \- Dependence syndrome (F1x.2\)
  • \- Personality disorder from F60 \- F63, excluding F63\.3 and F63\.8
  • \- early childhood developmental disorder (F84\.0, F84\.2, F84\.4, excl. F84\.5\) and mental retardation;
  • Highly intensive individual therapeutic work, continuous 1:1 care, acute need for treatment as well as acute self\- and/or external danger;
  • Control group: Participation in ADHD training from May 2018 during their rehabilitation stay between May and October 2018, as this was already implemented in standardized form from the new treatment concept as a test run.

Outcomes

Primary Outcomes

Not specified

Similar Trials